These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 34742741)

  • 1. Targeting alpha-synuclein via the immune system in Parkinson's disease: Current vaccine therapies.
    Fleming SM; Davis A; Simons E
    Neuropharmacology; 2022 Jan; 202():108870. PubMed ID: 34742741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease and alpha-synucleinopathies: from arising pathways to therapeutic challenge.
    Miraglia F; Betti L; Palego L; Giannaccini G
    Cent Nerv Syst Agents Med Chem; 2015; 15(2):109-16. PubMed ID: 25896035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson's disease.
    Geibl FF; Henrich MT; Xie Z; Zampese E; Ueda J; Tkatch T; Wokosin DL; Nasiri E; Grotmann CA; Dawson VL; Dawson TM; Chandel NS; Oertel WH; Surmeier DJ
    Mol Neurodegener; 2024 Oct; 19(1):69. PubMed ID: 39379975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson's Disease.
    Zella MAS; Metzdorf J; Ostendorf F; Maass F; Muhlack S; Gold R; Haghikia A; Tönges L
    Cells; 2019 Jan; 8(2):. PubMed ID: 30708997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.
    Galiano-Landeira J; Torra A; Vila M; Bové J
    Brain; 2020 Dec; 143(12):3717-3733. PubMed ID: 33118032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proSAAS Chaperone Provides Neuroprotection and Attenuates Transsynaptic α-Synuclein Spread in Rodent Models of Parkinson's Disease.
    Lindberg I; Shu Z; Lam H; Helwig M; Yucer N; Laperle A; Svendsen CN; Di Monte DA; Maidment NT
    J Parkinsons Dis; 2022; 12(5):1463-1478. PubMed ID: 35527562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A deadly spread: cellular mechanisms of α-synuclein transfer.
    Steiner JA; Angot E; Brundin P
    Cell Death Differ; 2011 Sep; 18(9):1425-33. PubMed ID: 21566660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of dopaminergic neuron loss in Parkinson's disease.
    Surmeier DJ
    FEBS J; 2018 Oct; 285(19):3657-3668. PubMed ID: 30028088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?
    Schulz-Schaeffer WJ
    Biomolecules; 2015 Jul; 5(3):1467-79. PubMed ID: 26193328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of α-Synuclein in Parkinson's Disease: From a Neuron-Glia Crosstalk Perspective.
    Yi S; Wang L; Wang H; Ho MS; Zhang S
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alpha-synuclein interacted proteins: the relevance with the pathogenesis of Parkinson's disease].
    Xu F; Luo JH; Jin JH
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 37(5):524-30. PubMed ID: 18925724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha synuclein dimers and oligomers are increased in overexpressing conditions in vitro and in vivo.
    Marmolino D; Foerch P; Atienzar FA; Staelens L; Michel A; Scheller D
    Mol Cell Neurosci; 2016 Mar; 71():92-101. PubMed ID: 26711807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
    Irizarry MC; Growdon W; Gomez-Isla T; Newell K; George JM; Clayton DF; Hyman BT
    J Neuropathol Exp Neurol; 1998 Apr; 57(4):334-7. PubMed ID: 9600226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's Disease: Exploring Different Animal Model Systems.
    Khan E; Hasan I; Haque ME
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy.
    Joers V; Murray BC; McLaughlin C; Oliver D; Staley HE; Coronado J; Achat-Mendes C; Golshani S; Kelly SD; Goodson M; Lee D; Manfredsson FP; Moore Ii BM; Tansey MG
    J Neuroinflammation; 2024 Sep; 21(1):240. PubMed ID: 39334169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathological mechanisms of Parkinson's disease].
    Matsui H; Takahashi R
    Brain Nerve; 2009 Apr; 61(4):441-6. PubMed ID: 19378814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice.
    Luk KC; Kehm V; Carroll J; Zhang B; O'Brien P; Trojanowski JQ; Lee VM
    Science; 2012 Nov; 338(6109):949-53. PubMed ID: 23161999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.